Novo Nordisk is working with OpenAI on a broad deal that will use artificial intelligence to more quickly develop new medications as well as help train its workforce.
www.marketwatch.com
#Novo #Nordisks #stock #rallied #drugmaker #reveals #deal #OpenAI
Novo Nordisk’s stock rallied after drugmaker reveals deal with OpenAI
